» Articles » PMID: 19071231

Inhibitory Effects of Flavonoids Extracted from Licorice on Lipopolysaccharide-induced Acute Pulmonary Inflammation in Mice

Overview
Date 2008 Dec 17
PMID 19071231
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Airway inflammation plays important roles in the pathogenesis of acute respiratory distress syndrome (ARDS), asthma and chronic obstructive pulmonary disease (COPD), and anti-inflammatory treatment effectively improves the symptoms of these diseases. To develop the potentially therapeutic compounds for the treatment of pulmonary inflammation, we investigated the effects of licorice flavonoids (LF) extracted from the roots of Glycyrrhiza uralensis (licorice) on lipopolysaccharide (LPS)-induced acute pulmonary inflammation in mice. Acute pulmonary inflammation was induced by intracheal instillation with LPS, treatment with LF at dosages of 3, 10 and 30 mg/kg significantly reduced the LPS-induced inflammatory cells, including neutrophils, macrophages and lymphocytes accumulation in bronchoalveolar lavage fluids (BALF), among these inflammatory cells, LF predominately inhibited neutrophil infiltration, and the maximal effect (30 mg/kg) was as comparable as dexamethasone treatment at 1 mg/kg. Consistent with its effects on neutrophil infiltration, LF treatment significantly increased LPS-induced BALF superoxide dismutase activity, and significantly decreased lung myeloperoxidase activity as well. Furthermore, treatment with LF at 30 mg/kg significantly reduced LPS-induced lung TNFalpha and IL-1beta mRNA expression at 6 h and 24 h after LPS instillation, respectively. Finally, LF at different dosages not only significantly decreased the elevation of lung water content, but also markedly attenuated LPS-induced histological alteration. Therefore, we suggest that LF effectively attenuates LPS-induced pulmonary inflammation through inhibition of inflammatory cells infiltration and inflammatory mediator release which subsequently reduces neutrophil recruitment into lung and neutrophil-mediated oxidative injury, and this study provides with the potential rationale for development of anti-inflammatory compounds from flavonoid extracts of licorice.

Citing Articles

Herbal Treatment of COPD and Asthma According to Persian Medicine: a Review of Current Evidence.

Baniamerian R, Tahermohammadi H, Daneshfard B, Agin K, Sadr S, Kaveh S Tanaffos. 2024; 22(2):187-199.

PMID: 38628881 PMC: 11016916.


Traditional Tibetan medicine: therapeutic potential in lung diseases.

Li C, Li Y, Huang X, Li S, Sangji K, Gu R Front Pharmacol. 2024; 15:1365911.

PMID: 38567353 PMC: 10986185. DOI: 10.3389/fphar.2024.1365911.


Targeted degradation of hexokinase 2 for anti‑inflammatory treatment in acute lung injury.

Yang J, Dong L, Wang Y, Gong L, Gao H, Xie Y Mol Med Rep. 2024; 29(5).

PMID: 38516767 PMC: 10975098. DOI: 10.3892/mmr.2024.13206.


Genetic Polymorphisms of and Genes and Smoking Susceptibility in the Saudi Population.

Al-Zahrani M, Almutairi N J Pharm Bioallied Sci. 2024; 15(4):180-189.

PMID: 38235052 PMC: 10790742. DOI: 10.4103/jpbs.jpbs_365_23.


Inhalation of panaxadiol alleviates lung inflammation inhibiting TNFA/TNFAR and IL7/IL7R signaling between macrophages and epithelial cells.

Wang Y, Wei H, Song Z, Jiang L, Zhang M, Lu X J Ginseng Res. 2024; 48(1):77-88.

PMID: 38223829 PMC: 10785239. DOI: 10.1016/j.jgr.2023.09.002.